PRAJMALIUM

Possibly Marketed Outside US

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C23H33N2O2
Molecular Weight	369.5203
Optical Activity	UNSPECIFIED
Defined Stereocenters	10 / 10
E/Z Centers	0
Charge	1

SHOW SMILES / InChI

Structure Search

SMILES

CCC[N@@+]12[C@H]3C[C@]45[C@H](O)[C@H]3[C@@H](C[C@H]1[C@@H]4N(C)C6=CC=CC=C56)[C@H](CC)[C@H]2O

InChI

InChIKey=UAUHEPXILIZYCU-ALHOSYKFSA-N

InChI=1S/C23H33N2O2/c1-4-10-25-17-11-14(13(5-2)22(25)27)19-18(25)12-23(21(19)26)15-8-6-7-9-16(15)24(3)20(17)23/h6-9,13-14,17-22,26-27H,4-5,10-12H2,1-3H3/q+1/t13-,14-,17-,18-,19-,20-,21+,22+,23+,25-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C23H32N2O2
Molecular Weight	368.5124
Charge	0
Count

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	9 / 10
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1694924 | https://www.ncbi.nlm.nih.gov/pubmed/6723753 | https://www.ncbi.nlm.nih.gov/pubmed/4029242

Neo-Gilurythmal (or prajmaline), an antiarrhythmic agent, which is used to treat angina pectoris, Wolff–Parkinson–White Syndrome and coronary artery disease. Neo-Gilurythmal found to be effective even in the case where other previously used antiarrhythmics were ineffective.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
sodium channel complex 2 Target ID: GO:0034706 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2422563\|https://www.ncbi.nlm.nih.gov/pubmed/1886140\|https://www.ncbi.nlm.nih.gov/pubmed/2410054\|https://www.ncbi.nlm.nih.gov/pubmed/6249418	Blocker 555

PubMed

Title	Date	PubMed
The structure of the ring-opened N beta-propyl-ajmaline (Neo-Gilurytmal) at physiological pH is obviously responsible for its better absorption and bioavailability when compared with ajmaline (Gilurytmal).	2000-07	10944783
Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy.	1990-06	1694924
Effects of oral prajmaline bitartrate on exercise test responses in patients with coronary artery disease.	1985	4029242
[Efficacy of prajmaline (Neo-Gilurytmal) objectifiable by means of a test].	1983-05-05	6190722

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Other

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:24:44 GMT 2025` Edited by `admin` on `Mon Mar 31 18:24:44 GMT 2025`
Record UNII	75934UD4GJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PRAJMALIUM

Common Name

English

PRAJMALINE

Preferred Name

English

Prajmalium [WHO-DD]

Common Name

English

AJMALANINE, 17,21-DIHYDROXY-4-PROPYL-, (17R,21.ALPHA.)-

Common Name

English

PRAJMALIUM CATION

Common Name

English

PRAJMALINE [MI]

Common Name

English

N-PROPYLAJMALINE

Common Name

English

PRAJMALIUM ION

Common Name

English

Classification Tree Code System Code

WHO-ATC

C01BA08